Author(s)

Margarita Cheido, Galina Idova, Elizaveta Alperina

Laboratory of the Mechanisms of Neurochemical Modulation, State Research Institute of Physiology and Basic Medicine, Siberian Branch of the Russian Academy of Medical Sciences, Novosibirsk, Russia..

The purpose of the present study was to analyze the effect of activation of mu-opioid receptors (mu-OR) on the immune response under blockade of postsynaptic D₁-and D₂-receptors in mice of the C57BL/6J strain displaying either aggressive or depressive-like behaviors in the social conflict model. It is shown that activation of activation of mu-OR with a highly selective agonist DAGO (100 μg/kg) increased significantly IgM-immune response not only in C57BL/6J mice with an unchanged psychoemotional state but also in mice displaying aggressive or depressive-like behaviors in the social stress model (10 days of agonistic confrontations). Selective blockade of DA receptors of the D₁-type with SCH-23390 (1.0 mg/kg with DAGO administration) caused a more pronounced elevation of IgM-immune response than DAGO alone while DAGO effect was completely blocked by prior administration of D₂-receptor antagonist haloperidol (1.0 mg/kg). At the same time, both SCH-23390 and haloperidol prevented the immune response increase induced by DAGO injection in mice engaged in aggressive or depressive-like behaviors. Thus, in animals not subjected to social stress DAGO-induced immunostimulation is provided only by D₂-receptors, whereas in animals with altered psychoemotional state mu-opioid immunostimulation is mediated by both types of DA receptors—D₁ and D₂. These data provide evidence for different impacts of the main subtypes of DA receptors in the mediation of immunomodulating effects of mu-opioid system under normal and stressful conditions.

Mu-Opioid and Dopamine Receptors; Social Stress; Aggression; Depressive-Like Behavior; Immunomodulation

M. Cheido, G. Idova and E. Alperina, "Dopamine D₁- and D₂-Receptors in Immunostimulation under Activation of Mu-Opioid Receptors in Mice with Different Psychoemotional States," Pharmacology & Pharmacy, Vol. 5 No. 1, 2014, pp. 43-48. doi: 10.4236/pp.2014.51008.